XOMA Corporation (XOMA) Financials

XOMA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 234.3 million 145.6 million
2023-09-30 124.1 million 18.1 million
2023-06-30 125.7 million 15.5 million
2023-03-31 133.7 million 19.1 million

XOMA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -18.6 million 2.6 million
2023-09-30 -2.1 million 2.7 million
2023-06-30 -7.2 million 2.2 million
2023-03-31 -4.9 million 1.6 million

XOMA Net Income

No data available :(

XOMA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 153.6 million - 389000
2023-09-30 33.7 million - -
2023-06-30 31.8 million - 17000
2023-03-31 44.6 million - 69000

XOMA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 11.5 million
2023-09-30 11.5 million
2023-06-30 11.5 million
2023-03-31 11.5 million

XOMA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 14.7 million 25000 7.3 million 1000
2023-09-30 - 25000 6.4 million -
2023-06-30 - 39000 5.8 million -
2023-03-31 - 54000 6.2 million -

XOMA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.8 million 225000
2023-09-30 830000 224000
2023-06-30 1.7 million 224000
2023-03-31 437000 225000

XOMA

Price: $25.02

52 week price:
13.48
27.00

Earnings Per Share: -4.04 USD

P/E Ratio: -7.26

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 14100

Ebitda: 28.3 million

Market Capitalization: 294.6 million

Links: